Abveris Announces Antibody Discovery Agreement with Immunitas Using the Berkeley Lights Beacon®

Oct 7, 2020

CANTON, Mass., Oct. 8, 2020 /PRNewswire/ -- Abveris, Inc. ("Abveris") announced today that it has entered into an agreement with Immunitas Therapeutics, Inc. ("Immunitas") for the discovery of monoclonal antibodies to expand the Immunitas therapeutic pipeline. Under the terms of the agreement, Abveris will utilize its proprietary DiversimAbTM mouse model in combination with its next-generation B cell screening platform, powered by the Berkeley Lights Beacon®, to rapidly discover monoclonal antibodies for use as research reagents and therapeutics for immuno-oncology.

"The Immunitas team is uniquely positioned to identify novel therapeutic oncology targets using their innovative single cell genomics-based techniques. Pairing the Immunitas platform with efficient discovery of highly diverse panels of antibodies will result in the rapid identification of therapeutic-quality antibodies," commented Tracey Mullen, CEO of Abveris. "Our function-forward approach to antibody discovery will enable Abveris to deliver fully validated drug candidates in accelerated timelines. Ultimately, the synergy between the two platforms will result in faster delivery of targeted therapies to the patients who need them."

"We are excited to collaborate with Abveris to accelerate the pace of discovery for some of our new antibody therapeutics," said Jeff Goldberg, CEO of Immunitas. "Our platform rapidly generates and validates new targets for treating challenging cancers. Working with Abveris will enable us to quickly identify and select highly specific antibodies for those targets, so that we can take the best antibody forward to address the needs of particular patient populations."

About Abveris:

Abveris is Boston's premier antibody discovery company providing contract research services to the biopharma industry. Abveris applies advanced immunization methods combined with B cell screening and hybridoma-based antibody discovery technologies to provide comprehensive gene-to-antibody discovery services. Abveris is developing the next generation of biologics, cell therapies, vaccines, and diagnostics in agreement with global leaders in biopharma. Additional information about Abveris is available at www.ABVERIS.com.

Contact:
Ryan Kelly
Director of Business Development

[email protected]

(781) 562-1170 x 1002

SOURCE Abveris Inc.

More News

Oct 11, 2026

Anguilla to host CTO’s inaugural Sports Tourism Summit in 2027

Anguilla will host the inaugural Caribbean Tourism Organization (CTO) Sports Tourism Summit, Aug. 12-14, 2027, creating a new regional platform focused on harnessing the growing intersection of sports, tourism and economic development. The announcement was made during CTO’s State of the Tourism Industry Conference (SOTIC) in Georgetown, Guyana, where Caribbean tourism leaders met under the theme “Tourism Futures: Smart, Sustainable and Inclusive.”

Oct 11, 2026

This Gen Z designer nearly left the industry. Now, he is redefining luxury fashion

“I’m not a fashion person,” says Kenneth Chow, founder of independent fashion label Chow Chow. During our interview, he wears a simple striped shirt and answers without pretension. “I barely buy new clothes,” he says, laughing. Despite his simple approach to fashion, Chow’s business focuses on refined craftsmanship, intricate designs and handcrafted luxury. His designs, embellished with crystals and pearls hand-stitched on dark-coloured silks, play with perceptions of geometry and linear...

Oct 11, 2026

Touring Tuscany for Piero della Francesca’s Most Resplendent Artworks

A writer’s road trip in search of the early Renaissance master’s most resplendent works takes her to towns beyond Florence, the birthplace of the Italian Renaissance.

Oct 11, 2026

Glastonbury Isn't The Only Festival On The 2027 Calendar, And These 5 European Events Prove It

Fear not, your summer plans will be saved... View Entire Post ›

Oct 10, 2026

The plague isn’t history. Where it still exists, how it spreads and a cure

To most, the plague is an ancient nightmare, a scourge that wiped out tens of millions in medieval Europe and killed more than 20,000 people in colonial Hong Kong between 1894 and 1929. A recent death at a plague research facility in Siberia is a stark reminder that the bacterium that causes it, Yersinia pestis, was never eradicated. While modern medicine has transformed the former “Black Death” into an easily treatable bacterial infection, the disease continues to circulate quietly across the...

Oct 10, 2026

Conor Kennedy and Giulia Be Married in Rio

The couple’s three-day wedding celebration in Rio de Janeiro brought together two families with political ties as rising tensions surround Brazil’s presidential election.

Oct 10, 2026

Meet Thomas Eisenhood, Jessica Simpson’s rumoured new boyfriend

Jessica Simpson seems to be cosying up to her rumoured new beau. On October 5, TMZ reported that the 46-year-old singer and actress was spotted enjoying a Sunday morning walk at Albuquerque’s Balloon Fiesta Park with 33-year-old musician Thomas Eisenhood, whom she was first linked to in April. According to TMZ, the pair had been dating for roughly three months when the outlet broke the news in April. A source confirmed the relationship to People, adding, “[Simpson is] happy. She’s in a great...

Oct 10, 2026

Travel leaders gather in Jamaica for World Travel Awards Caribbean & The Americas Gala Ceremony 2026

Jamaica is preparing to welcome travel and tourism leaders from across the region for the World Travel Awards Caribbean & The Americas Gala Ceremony 2026. The ceremony is taking place at Princess Grand Jamaica on 11 October 2026, forming the flagship evening of World Travel Week Jamaica.

Oct 10, 2026

Just 37 Travel Products For Anyone Who Wants To Be Over-Prepared In The Best Way

Prepare to be the MVP of your travel buddy group. View Entire Post ›

Oct 10, 2026

Why freaky shoes from Saint Laurent, Chanel and Dior are trending

There is something quite deliciously subversive about a freaky shoe. Feet of course already hold a hint of perversion – some people are really into them, while others find them repellent. But shod those feet in a shoe that people can find both compelling and strange? Well actually, that’s fashion catnip. Visceral proof can be found in those who have made the freaky shoe their signature, such as the aristocratic, enigmatic and entirely iconic Daphne Guinness, who always wears a pair of...

Oct 10, 2026

9 Injured After J.F.K.-Bound Flight Hits Severe Turbulence

Avianca Flight 42 was en route to New York from Medellín, Colombia, when it “encountered unexpected turbulence” and was diverted to Miami.

Oct 10, 2026

What Travelers Need to Know as Isaias Pushes Inland

The storm, which closed airports and canceled trains along the Gulf, could affect major hubs like Atlanta and Charlotte.